Ribosomal Protein S8 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of Ribosomal Protein S8, a critical component of the small subunit of the ribosome. Ribosomal Protein S8 plays an essential role in ribosome assembly and function, as it helps stabilize the structure of the ribosome and facilitates the proper alignment of ribosomal RNA (rRNA) and messenger RNA (mRNA) during protein synthesis. In particular, S8 is involved in the binding and folding of 16S rRNA, a crucial step in the formation of the functional ribosomal complex. By inhibiting Ribosomal Protein S8, these compounds can interfere with the assembly of the ribosome, thereby disrupting the fundamental process of translation in the cell.
The development of Ribosomal Protein S8 inhibitors requires a deep understanding of the protein's structure, especially its binding interfaces with rRNA and other ribosomal proteins. These inhibitors typically work by binding to the critical regions of S8, such as its RNA-binding domain, blocking its interaction with rRNA and preventing the proper assembly of the small ribosomal subunit. Structural biology techniques, including X-ray crystallography and cryo-electron microscopy, are employed to map these key sites and to guide the design of inhibitors that specifically target S8 without affecting other ribosomal proteins. Specificity is essential because ribosomal proteins have highly conserved roles in translation across different species, and off-target effects could disrupt other components of the ribosome. Ribosomal Protein S8 inhibitors serve as valuable tools for studying the mechanisms of ribosome biogenesis, translation regulation, and protein synthesis, offering insights into how this critical protein influences cellular growth and metabolic processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Could inhibit mTORC1, possibly affecting protein synthesis and RPS8 expression indirectly. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Might cause premature termination of translation, potentially affecting the synthesis of RPS8. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Could inhibit thymidylate synthase, affecting DNA replication and possibly the expression of RPS8. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
May inhibit inosine monophosphate dehydrogenase, potentially affecting guanine nucleotide synthesis and RPS8 expression. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Might crosslink DNA, inhibiting transcription and thereby possibly reducing RPS8 expression. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Could intercalate into DNA, affecting transcription and possibly the expression of RPS8. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Might inhibit DNA topoisomerase I, potentially affecting DNA replication and RPS8 expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Could inhibit DNA topoisomerase II, affecting DNA replication and possibly RPS8 expression. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
May inhibit ribonucleotide reductase, affecting DNA synthesis and potentially RPS8 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Could cause DNA demethylation, potentially affecting gene expression, including that of RPS8. | ||||||